The Worldwide Biobanking Industry is Expected to Reach $3.6 Billion by 2027

Dublin, Aug. 12, 2022 (GLOBE NEWSWIRE) -- The "Global Biobanking Market (2022-2027) by Product & Service, Sample, Storage, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to's offering.

The Global Biobanking Market is estimated to be USD 2.52 Bn in 2022 and is expected to reach USD 3.65 Bn by 2027, growing at a CAGR of 7.71%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.

There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are AMS Biotechnology, Bay Biosciences, Becton, Dickinson and Company, Bioivt & Elevating Science, Boca Biolistics, etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Biobanking Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Biobanking Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position. Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Biobanking Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's Proprietary competitive positioning tool.

Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics
4.1 Drivers
4.1.1 Growing Cost-Effective Drug Discovery and Development and
4.1.2 Genomic Research Activities
4.1.3 Advances in Biobanking and Growing Trend of Conserving Cord Blood Stem Cells of Newborns
4.1.4 Government and Private Funding to Support Regenerative Medicine Research
4.2 Restraints
4.2.1 High Cost of Automation
4.2.2 Issues Related to Biospecimen Sample Procurement
4.3 Opportunities
4.3.1 Emerging Countries
4.3.2 Growing Focus on the R&D of Cell Therapies
4.4 Challenges
4.4.1 Long-Term Sustainability of Biobanks

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis

6 Global Biobanking Market, By Product & Service
6.1 Introduction
6.2 Equipment
6.2.1 Storage Equipment
6.2.2 Sample Analysis Equipment
6.2.3 Sample Processing Equipment
6.2.4 Sample Transport Equipment
6.3 Consumables
6.3.1 Storage Consumables
6.3.2 Analysis Consumables
6.3.3 Processing Consumables
6.3.4 Collection Consumables
6.4 Services
6.4.1 Storage Services
6.4.2 Processing Services
6.4.3 Transport Services
6.4.4 Supply Services

7 Global Biobanking Market, By Sample
7.1 Introduction
7.2 Blood Products
7.3 Human Tissues
7.4 Cell Lines
7.5 Nucleic Acids
7.6 Biological Fluids
7.7 Human Waste Products

8 Global Biobanking Market, By Storage
8.1 Introduction
8.2 Manual Storage
8.3 Automated Storage

9 Global Biobanking Market, By Application
9.1 Introduction
9.2 Regenerative Medicine
9.3 Life Science Research
9.4 Clinical Research

10 Americas Biobanking Market
10.1 Introduction
10.2 Argentina
10.3 Brazil
10.4 Canada
10.5 Chile
10.6 Colombia
10.7 Mexico
10.8 Peru
10.9 United States
10.10 Rest of Americas

11 Europe's Biobanking Market
11.1 Introduction
11.2 Austria
11.3 Belgium
11.4 Denmark
11.5 Finland
11.6 France
11.7 Germany
11.8 Italy
11.9 Netherlands
11.10 Norway
11.11 Poland
11.12 Russia
11.13 Spain
11.14 Sweden
11.15 Switzerland
11.16 United Kingdom
11.17 Rest of Europe

12 Middle East and Africa's Biobanking Market
12.1 Introduction
12.2 Egypt
12.3 Israel
12.4 Qatar
12.5 Saudi Arabia
12.6 South Africa
12.7 United Arab Emirates
12.8 Rest of MEA

13 APAC's Biobanking Market
13.1 Introduction
13.2 Australia
13.3 Bangladesh
13.4 China
13.5 India
13.6 Indonesia
13.7 Japan
13.8 Malaysia
13.9 Philippines
13.10 Singapore
13.11 South Korea
13.12 Sri Lanka
13.13 Thailand
13.14 Taiwan
13.15 Rest of Asia-Pacific

14 Competitive Landscape
14.1 Competitive Quadrant
14.2 Market Share Analysis
14.3 Strategic Initiatives
14.3.1 M&A and Investments
14.3.2 Partnerships and Collaborations
14.3.3 Product Developments and Improvements

15 Company Profiles
15.1 AMS Biotechnology
15.2 Bay Biosciences
15.3 Becton, Dickinson and Company
15.4 Bioivt & Elevating Science
15.5 Boca Biolistics
15.6 CTI Biotech
15.7 Cureline
15.8 Cureline
15.9 Firalis
15.10 Geneticist
15.11 Greiner Holding AG
15.12 Hamilton Company
15.13 Merck KGaA
15.14 Panasonic Healthcare Holdings
15.15 Promega
15.16 Proteogenex
15.17 Qiagen N.V.
15.18 Tecan Trading
15.19 Thermo Fisher Scientific
15.20 US Biolab Corp
15.21 VWR International

16 Appendix

For more information about this report visit


Global Biobanking Market

Contact Data